Karyopherin α-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3Anna Sowa, Thorsten Schmidt, Franziska Rother et al.|Proceedings of the National Academy of Sciences|2018Cited by 48
<i>In vivo</i> assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3Jana Schmidt, Olaf Rieß, Thorsten Schmidt et al.|Journal of Neurochemistry|2016Cited by 34
Mitochondrial Dysfunction in Spinocerebellar Ataxia Type 3 Is Linked to VDAC1 DeubiquitinationTina Harmuth, Jeannette Hübener‐Schmid, Jonasz Jeremiasz Weber et al.|International Journal of Molecular Sciences|2022Cited by 25
Vulnerability of frontal brain neurons for the toxicity of expanded ataxin-3Jana Schmidt, Thorsten Schmidt, Olaf Rieß et al.|Human Molecular Genetics|2018Cited by 12